Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis

Journal article

Peer reviewed

Adam Rischin, Thilinie De Silva, Kim Le Marshall and Fernando Oneissi Martinez Estrada

Rheumatology (Oxford, England), Vol.58(6), pp.1111-1113

01/06/2019

PMID: 30753711

Abstract

Antirheumatic Agents - adverse effects

Arthritis, Rheumatoid - drug therapy

Arthritis, Rheumatoid - genetics

Female

Fibroma - chemically induced

Humans

Middle Aged

Neurofibromatosis 1 - complications

Neurofibromatosis 1 - genetics

Piperidines - adverse effects

Pyrimidines - adverse effects

Pyrroles - adverse effects

Skin Neoplasms - chemically induced

3 Record Views

Title: Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis
Creators: Adam Rischin - Western Health
Thilinie De Silva - Western Health
Kim Le Marshall - University of Melbourne
Fernando Oneissi Martinez Estrada - School of Biosciences
Publication Details: Rheumatology (Oxford, England), Vol.58(6), pp.1111-1113
Publication Date: 01/06/2019
Identifiers: 99961148102346; WOS:000475753800030
Academic Unit: School of Biosciences
Language: English
Resource Type: Journal article